Genetic Industries Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.33 M
- Revenue Growth -36.86%
- Profit Growth -25.34%
- Ebitda -28.35%
- Net Worth 34.68%
- Total Assets 24.36%
About Genetic Industries
Genetic Industries Private Limited (GIPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 May 2015 (Nine years and nine months 2 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.33 M.
Mohammad Memon and Huma Madani serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U19100GJ2015PTC083078
- Company No.
083078
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 May 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Genetic Industries?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammad Memon  | Director | 01-May-2015 | Current |
| Huma Madani | Additional Director | 18-Oct-2017 | Current |
Financial Performance of Genetic Industries.
Genetic Industries Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.86% decrease. The company also saw a substantial fall in profitability, with a 25.34% decrease in profit. The company's net worth Soared by an impressive increase of 34.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genetic Industries?
In 2023, Genetic Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Welterman International LimitedHuma Madani is a mutual person
Charges (Loans)
₹0.23 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2023 | Hdfc Bank Limited | ₹2.33 M | Open |
How Many Employees Work at Genetic Industries?
Unlock and access historical data on people associated with Genetic Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genetic Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genetic Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
